I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let's see whether you should go long on any of this separate -although related - entities.
Good Operational Performance
Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:
Top Food Companies To Buy Right Now: TPC Group Inc.(TPCG)
TPC Group Inc. produces and sells value-added products derived from petrochemical raw materials to chemical and petroleum based companies in North America. The company operates in two segments, C4 Processing and Performance Products. The C4 Processing segment offers butadiene that is primarily used to produce synthetic rubber used in tires and other automotive products; butene-1, which is principally used in the manufacture of plastic resins and synthetic alcohols; raffinates that are primarily used to manufacture alkylate; and methyl tertiary butyl ether, which is principally used as a gasoline blending stock. The Performance Products segment provides high purity isobutylene, which is primarily used in the production of synthetic rubber, lubricant additives, surfactants, and coatings; conventional polyisobutylenes and highly reactive polyisobutylenes that are principally used in the production of fuel and lubricant additives, caulks, adhesives, sealants, and packaging; di isobutylene, which is primarily used in the manufacture of surfactants, plasticizers, and resins; and nonene and tetramer that are principally used in the production of plasticizers, surfactants, and lubricant additives. The company was formerly known as Texas Petrochemicals Inc. and changed its name to TPC Group Inc. in January 2010. TPC Group Inc. was founded in 1943 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By CRWE]
TPC Group Inc. (Nasdaq:TPCG), a leading fee-based processor and service provider of value-added products derived from niche petrochemical raw materials, reported that it has entered into a definitive merger agreement with investment funds sponsored by First Reserve Corporation, a leading global investment firm dedicated to the energy industry, and SK Capital Partners, a U.S. based private investment firm focused on the chemicals sector.
Hot Prefered Stocks To Own For 2014: Emerson Electric Company(EMR)
Emerson Electric Co. operates as a diversified manufacturing and technology company. The company engages in appliance solutions, climate technologies, industrial automation, motor technology, network power, process management, professional tools, and storage solutions businesses. Its appliance solutions business provides appliance controls, appliance motors, heating products, and white-rodgers; climate technology business provides heating, ventilation, air conditioning, and refrigeration (HVACR) solutions for residential, industrial, and commercial applications; and industrial automation business offers bearings and power transmission products, electrical power generation products, electric motors, variable speed drives and servos, electrical products, material joining solutions, fluid automation products, and wind turbine systems. The company?s motor technology business provides appliance motors, HVACR motors, DC motors, fractional horsepower motors, integral horsepower a nd larger motors, and drives; network power business provides power, precision cooling, connectivity, and embedded solutions; and process management business provides various wireless related products from self-organizing field networks to wireless asset and people tracking. Its professional tools business offers pipe working and threading equipment, pressing technology, utility locating and visual diagnostics systems, drain maintenance tools, power tools, air tools, general purpose hand tools, wet/dry vacs, job site storage equipment, truck tool boxes and equipment, and van storage equipment; and storage solutions business provides shelving and storage products for residential, commercial, and foodservice needs, as well as offers specialized carts, mobile computer workstations, and cabinet fixtures. The company was founded in 1890 and is headquartered in St. Louis, Missouri.
Advisors' Opinion:- [By Dividends4Life]
Related Articles
- Cincinnati Financial Corp. (CINF) Dividend Stock Analysis
- Exxon Mobil Corporation (XOM) Dividend Stock Analysis
- People's United Financial Inc. (PBCT) Dividend Stock Analysis
- Emerson Electric Co. (EMR) Dividend Stock Analysis
- More Stock Analysis
Hot Prefered Stocks To Own For 2014: Medical Marijuana Inc (MJNA.PK)
Medical Marijuana Inc. (MJNA), incorporated on May 23, 2005, is the publicly held company vested in the medical marijuana and industrial hemp markets. The Company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries. These products range from patented based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical and cosmeceutical industries. In March 2013, it sold certain equipment and inventory, web domain names, phone numbers, and all existing and pending agreements with hemp production and processing facilities to CannaVEST Corp.
The Company�� services are varied, ranging from medical clinic management to the capitalization and development of existing industry business and product leaders. Services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. MJNA provides over 50 and patented cannabinoid delivery methods that are more socially and medically acceptable than smoking.
Advisors' Opinion:- [By Alan Brochstein]
Taking into account all of the data I have shared, I want to introduce my take on the most important names to follow. My initial list takes into account not only the market cap, but also business model and interest level. These are the stocks that I think merit the most attention (in alphabetical order):
CannaVest (CANV.OB)GW Pharma (GWPH)MedBox (MDBX.PK)Medical Marijuana, Inc. (MJNA.PK)CANV doesn't really trade, as it is held closely by insiders (99.7%, including MJNA). I have a few concerns, including the valuation and some near-term financial challenges typical of a start-up with just one client looking to expand its customer base, but I like the focus and the fact that it is an SEC filer with a relatively clean history (i.e. none of the baggage of some of these other companies). I have spoken to its outsourced CFO and am impressed by his background (has been CFO or held key financial roles at publicly-traded healthcare companies). CANV is the partner to MJNA that is responsible for manufacturing the CBD (Cannibidiol, the cannabinoid in marijuana that is increasingly viewed as offering substantial medical benefits). I am very concerned about the near-term financials, but this is a pure-play with probably a two-year lead over other companies. I don't see a moat in terms of intellectual property or brands, but they have a good lead in terms of sourcing of supply and penetration into potential customers. Quite simply, they don't appear to have competition at present. The company, then, is a call option on CBD demand taking off. It appears that it could be a supplier to even Big Pharma should medical marijuana research move into the mainstream.
Hot Prefered Stocks To Own For 2014: MEDNAX Inc (MD)
MEDNAX, Inc. (MEDNAX), incorporated in 2007, is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care. As of December 31, 2011, the Company�� national network consisted of 1,839 affiliated physicians, including 996 physicians who provided neonatal clinical care, in 34 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company has 190 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. In March 2014, the Company acquired Piedmont Neonatology, P.C.Piedmont Neonatology, P.C, is a private neonatal physician group practice based in Greensboro, North Carolina.
MEDNAX�� network includes other pediatric subspecialists, including 108 physicians providing pediatric cardiology care, 85 physicians providing pediatric intensive care, 43 physicians providing hospital-based pediatric care and six physicians providing pediatric surgical care. In addition, it has 411 physicians who provide anesthesia care to patients in connection with surgical and other procedures, as well as pain management. The Company provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through a team of neonatal physician subspecialists (neonatologists), neonatal nurse practitioners and other pediatric clinicians. Neonatal nurse practitioners are nurses who have training and education in managing the healthcare needs of newborns, infants and their families.
MEDNAX provides outpatient and inpatient clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, such as maternal-fetal nurse practitioners, nurse mid-wives, ultrasonogra! phers and genetic counselors. It provides inpatient and outpatient pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through its affiliated pediatric cardiologist subspecialists and other clinicians, such as pediatric nurse practitioners, echocardiographers and other diagnostic technicians, and exercise physiologists.
The Company�� network includes pediatric intensivists, who are hospital-based pediatricians with education and training in caring for critically ill or injured children and adolescents, pediatric hospitalists, who are hospital-based pediatricians specializing in inpatient care and management of acutely ill children and pediatric surgeons, who provide specialized care for patients ranging from newborns to adolescents, for all problems or conditions affecting children that require surgical intervention. Its affiliated physicians also provide clinical services in other areas of hospitals, particularly in the labor and delivery area and nursery and pediatric department.
The Company provides anesthesia care through a team of physician anesthesiologists, certified registered nurse anesthetists (CRNAs) and anesthesia assistants (AAs). The Company also provides acute and chronic pain management services. Postoperative acute pain management is often initiated in the hospital recovery room and may continue for the remainder of the hospital stay. Chronic pain services are offered through outpatient medical offices or hospital clinics.
Advisors' Opinion:- [By Seth Jayson]
MEDNAX (NYSE: MD ) is expected to report Q2 earnings around July 30. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict MEDNAX's revenues will increase 18.4% and EPS will grow 11.5%. - [By Bryan Murphy]
Looking for some fresh trading ideas in a market environment that isn't offering many? Take a look at MEDNAX Inc. (NYSE:MD) and Westport Innovations Inc. (NASDAQ:WPRT). Though they're pointed in different directions, both MD and WPRT appear to be on the verge of trade-worthy moves. The fact that the two are nearly mirror images of one another is strictly coincidental.
No comments:
Post a Comment